The largest database of trusted experimental protocols

Athymic nude mice

Manufactured by Orient Bio

Athymic nude mice are a laboratory animal model characterized by the absence of a functional thymus gland, resulting in a deficiency of T cells. They are commonly used in biomedical research, particularly in the areas of cancer, immunology, and transplantation studies.

Automatically generated - may contain errors

12 protocols using athymic nude mice

1

Teratoma Formation from Pig ESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pig ESCs at 70%–80% confluence were used for transplantation. Approximately 5–10 × 106 ESCs were resuspended in 200 μL of ESC culture medium containing 50% (v/v) BD Matrigel Matrix (BD Biosciences, Franklin Lakes, NJ, USA) and 10 μM Y-27632. Next, the resuspended pig ESCs were injected subcutaneously into 5-week-old athymic nude mice (OrientBio). At 2–3 months after transplantation, 1- to 2-cm teratomas were collected, fixed in 4% (w/v) paraformaldehyde, embedded in paraffin, and stained with H&E for light microscopic examination.
For genotyping of teratomas, genomic DNA was extracted from teratomas and the peritoneum of athymic nude mice using the G-spin Total DNA Extraction Kit (iNtRON Biotechnology, Korea). Genomic DNA samples were amplified using 10 pmol of species-specific primers (Table S4) and 2× PCR master mix solution (iNtRON Biotechnology). PCR reactions were performed in a thermocycler under the following conditions: 95°C for 5 min; followed by 25 cycles of denaturation at 95°C for 30 s, annealing at 60°C for 30 s, and extension at 72°C for 30 s; with a final extension at 72°C for 7 min. Amplified PCR products were electrophoresed in 1% (w/v) agarose gels and stained with RedSafe Nucleic Acid Staining Solution (an alternative to ethidium bromide; iNtRON Biotechnology).
+ Open protocol
+ Expand
2

Combination Therapy for Pancreatic Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four-week-old female athymic nude mice were purchased from Orient Bio Inc. (Seongnam, Korea). Capan-1 cells were resuspended at 3×107 cells in 100 μL of phosphate-buffered saline and injected subcutaneously. The tumor volume was calculated using the formula: volume=[(width)2×height]/2. When the tumor volume reached 200 mm3, the mice were randomly assigned to four groups of five mice to receive (1) vehicle (2-hydroxypropyl-β-cyclodextrin solution), (2) AZD1775 once daily at 30 mg/kg for 4 weeks (5 days on/2 days off), (3) AZD0156, as described for (2), or (4) AZD1775 plus AZD0156, as descri-bed for (2). All treatments were administered by oral gavage. Body weights and tumor sizes were measured every other day.
+ Open protocol
+ Expand
3

Tumor-targeting Capacity of Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Athymic nude mice (6 weeks old, the average adult weight is 25 g) were purchased from OrientBio (Gwangju, South Korea). The animal experiment protocol was approved by Chonnam National University Animal Research Committee (CNU IACUC-H-2020-19). The cultured NCI-H460 cancer cells were suspended in 100 μL of PBS to inoculate subcutaneously into the right flank of each mouse (1 × 106 cells per mouse). At 8 and 10 days post-inoculation, the tumors of 1 cm or less in diameter were prepared to test the tumor-targeting capacity of the samples, as well as the PTT application. The mice injected intravenously with samples were euthanized for NIR fluorescence imaging during a designated period of time.
+ Open protocol
+ Expand
4

Serum Toxicity Profiling of Combination Therapies

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the serum toxicity profile of combination therapy regimens, an A549 human xenograft tumor model was established by subcutaneously injecting 1 × 107 cells into 6- to 8-week-old male athymic nude mice (Orientbio). Mice were randomized into three groups (PBS, GM101+SBHA, and GM101+MS-275) and treated in the same manner as described in Section 2.10. At 3 days after the last virus injection, mice were sacrificed then the serum was collected. The level of aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN), and creatinine (CRE) in serum samples were analyzed by DRI-CHEM NX700 chemistry analyzer (FUJIFILM, Tokyo, Japan)
+ Open protocol
+ Expand
5

Antitumor Efficacy of Treatments in U343 Xenograft Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the antitumor efficacy of different treatments, a U343 human xenograft tumor model was established subcutaneously by injecting 1 × 107 cells under the abdominal skin of 6- to 8-week-old male athymic nude mice (Orientbio, Seong-nam, Korea). Once the average tumor volumes reached 100 mm3, mice were randomized into six groups (PBS, SBHA, MS-275, GM101, GM101+SBHA, and GM101+MS-275) to begin treatments (designated as day 1). The mice were intraperitoneally injected with PBS, SBHA (200 mg/kg), or MS-275 (20 mg/kg) on day 1, 3, and 5. PBS or GM101 (5 × 109 VPs) were intratumorally administered on days 2, 4, and 6. The length (L) and width (W) of the tumor were measured every other day with a caliper to calculate tumor growth. The tumor volume was calculated according to the following formula: tumor volume = 0.523 × L × W2. All animal studies were conducted under the institutional guidelines of Hanyang University Institutional Animal Care and Use Committee.
+ Open protocol
+ Expand
6

Mouse Xenograft Model for Tumor Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
A mouse xenograft model was prepared by subcutaneously injecting T47D cells (1 × 107 cells in 100 μL PBS) into athymic nude mice (Orient Bio Inc.) implanted with 17β-estradiol pellets (Innovative Research of America). After tumor volumes reached 300 mm3, T47D tumor-bearing mice were intravenously administered with 2 mg of IG-LPNs or C-LPNs per mouse. One day post-dose, mice were irradiated with NIR. Next day, tumors were extracted, fixed in 4% paraformaldehyde for 24 h, and embedded in paraffin. Tumor tissues were sectioned at a thickness of 3 μmol/L and stained with hematoxylin and eosin (H&E). Apoptotic cells in vivo were detected by terminal deoxy nucleotidyl transferase-mediated dUTP Nick end labeling (TUNEL) assay using ApopTag® Peroxidase In Situ Apoptosis Detection Kit (Merck Millipore) according to the manufacturer's protocols. The tumor tissues were observed using a Pannoramic MIDI digital slide scanner (3DHISTECH Ltd., Budapest, Hungary).
+ Open protocol
+ Expand
7

Visualizing Nanoparticle Biodistribution in Xenograft Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal studies were conducted according to Guidelines for the Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources in Seoul National University (approved animal experimental protocol number, SNU-190216-1). A mouse xenograft model was prepared by subcutaneously injecting T47D cells (1 × 107 cells in 100 μL PBS) into athymic nude mice (Orient Bio Inc., Seongnam, Republic of Korea) implanted with 17β-estradiol pellets (Innovative Research of America, Sarasota, FL, USA). After tumor volumes reached 300 mm3, tumor-bearing mice were intravenously administered with 2 mg of Cy5-labelled IG-LPNs or Cy5-labelled C-LPNs per mouse. For the fluorescence labelling, Cy5-conjugated lipid was used. Whole body distribution of the Cy5-labelled nanoparticles was imaged by near infrared fluorescent imaging system AMI-HT (Spectral Imaging Instruments, Tucson, AZ, USA) at various time points. At 48 h post-injection, main organs and tumor tissues were collected for ex vivo imaging.
+ Open protocol
+ Expand
8

Tumor Regression in Athymic Nude Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four-week-old female athymic nude mice were purchased from Orient Bio Inc. (Seongnam, Korea). SNU869 cells (1×107 cells) were subcutaneously injected into each mouse. When the tumor volume reached 250 mm3, the mice were randomly divided into four groups of five mice each. Olaparib (50 mg/kg) and AZD1775 (25 mg/kg) were administered orally once a day for 4 weeks (5 days on/2 days off), and the control group was treated with vehicle (0.5% methyl cellulose, Sigma-Aldrich) via oral gavage. Body weight and tumor size were measured every other day. The tumor volume was calculated using the following formula: tumor volume=[(width)2×height]/2.
+ Open protocol
+ Expand
9

In Vivo Evaluation of Light-Triggered Liposomal Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
A mouse xenograft model was prepared by subcutaneously injecting T47D cells (1 × 107 cells in 100 μL PBS) into athymic nude mice (Orient Bio Inc.) implanted with 17β-estradiol pellets (Innovative Research of America). After tumor volumes reached ∼300 mm3, tumor-bearing mice were intravenously administered 2 mg of IG-LPNs or C-LPNs per mouse. Twenty-four hours later, mice were irradiated at three sites on the tumor with NIR (808 nm) for 5 min at a power of 1.2 W using a light-emitting diode (BWT Beijing), and then the temperature of mice was measured using an infrared camera (FLIR Systems Inc.). Tumor volume and body weight were measured twice a week. Tumor volume was calculated according to Eq. (5): Tumorvolume=Length×Width2/2
+ Open protocol
+ Expand
10

Athymic Nude Mice Maintenance Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six-week-old athymic nude mice (Orientbio, Seongnam, Korea) were maintained in a laminar air-flow cabinet with specific pathogen-free conditions. All facilities were approved by the Association for Assessment and Accreditation of Laboratory Animal Care. All animal studies were performed according to the institutionally approved protocols of Hanyang University.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!